Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07321 | 32540177 | J Hepatol | Blocking integrin α4β7-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis. | 2020 | Details |
| A07323 | 32537840 | Hepatol Res | Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: Data from Hong Kong. | 2020 | Details |
| A07325 | 32536770 | World J Gastroenterol | Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. | 2020 | Details |
| A07329 | 32534989 | Chem Biol Interact | Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease. | 2020 | Details |
| A07330 | 32534588 | Cardiovasc Diabetol | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. | 2020 | Details |
| A07333 | 32533233 | Pathologe | [Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease]. | 2020 | Details |
| A07338 | 32531442 | Ann Diagn Pathol | Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD. | 2020 | Details |
| A07342 | 32531295 | Metabolism | Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. | 2020 | Details |
| A07344 | 32530991 | J Gastrointestin Liver Dis | Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice. | 2020 | Details |
| A07350 | 32529354 | Obes Surg | Correlation between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease before and after Metabolic Bariatric Surgery. | 2020 | Details |
| A07358 | 32526788 | Semin Liver Dis | The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07360 | 32526784 | Semin Liver Dis | Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. | 2020 | Details |
| A07361 | 32526482 | Cell Mol Gastroenterol Hepatol | Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. | 2020 | Details |
| A07365 | 32524859 | Expert Opin Drug Discov | How effective are nonalcoholic fatty liver disease models for drug discovery? | 2020 | Details |
| A07368 | 32524096 | Hawaii J Health Soc Welf | Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i. | 2020 | Details |
| A07370 | 32523627 | Therap Adv Gastroenterol | Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. | 2020 | Details |
| A07371 | 32523319 | World J Gastroenterol | Association between non-alcoholic fatty liver disease and obstructive sleep apnea. | 2020 | Details |
| A07373 | 32523101 | Sci Rep | Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools. | 2020 | Details |
| A07377 | 32521615 | Cancers (Basel) | Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response. | 2020 | Details |
| A07379 | 32520458 | Rev Med Suisse | [NASH: a less known but severe complication of diabetes]. | 2020 | Details |
| A07383 | 32518675 | Clin Diabetes Endocrinol | Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | 2020 | Details |
| A07384 | 32518428 | Clin Biochem Rev | Serum Marker Panels for Predicting Liver Fibrosis - An Update. | 2020 | Details |
| A07385 | 32518275 | Sci Rep | The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07388 | 32518095 | CMAJ Open | Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study. | 2020 | Details |
| A07390 | 32516937 | Int J Mol Sci | Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07392 | 32516028 | Am J Physiol Endocrinol Metab | NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice. | 2020 | Details |
| A07394 | 32515880 | Liver Int | Mechanisms for increased risk of diabetes in chronic liver diseases. | 2020 | Details |
| A07395 | 32515534 | Hepatol Res | Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. | 2020 | Details |
| A07397 | 32514497 | JHEP Rep | Combined alcoholic and non-alcoholic steatohepatitis. | 2020 | Details |
| A07398 | 32514465 | JGH Open | No association between binge eating disorder and severity of non-alcoholic fatty liver disease in severely obese patients. | 2020 | Details |
| A07399 | 32514460 | JGH Open | Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study. | 2019 | Details |
| A07402 | 32514444 | JGH Open | Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease. | 2019 | Details |
| A07408 | 32512581 | PLoS One | Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet. | 2020 | Details |
| A07409 | 32512191 | Biochim Biophys Acta Mol Basis Dis | Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells. | 2020 | Details |
| A07410 | 32512072 | Toxicol Appl Pharmacol | Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats. | 2020 | Details |
| A07414 | 32509277 | F1000Res | Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease. | 2020 | Details |
| A07427 | 32504663 | J Hepatol | Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. | 2020 | Details |
| A07429 | 32502647 | Biochim Biophys Acta Mol Basis Dis | The role of AMPKα2 in the HFD-induced nonalcoholic steatohepatitis. | 2020 | Details |
| A07431 | 32502037 | Medicine (Baltimore) | Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease. | 2020 | Details |
| A07433 | 32499209 | J Formos Med Assoc | Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. | 2020 | Details |
| A07443 | 32494762 | Curr Dev Nutr | Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models. | 2020 | Details |
| A07447 | 32492133 | J Biochem | Arachidonate 12S-lipoxygenase of platelet-type in hepatic stellate cells of methionine and choline-deficient diet-fed mice. | 2020 | Details |
| A07448 | 32492075 | PLoS One | Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis. | 2020 | Details |
| A07449 | 32491288 | Physiol Int | Betanin effect on PPAR-α and SREBP-1c expression in NMRI mice model of steatohepatitis with fibrosis. | 2020 | Details |
| A07450 | 32490903 | Arq Gastroenterol | PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY. | 2020 | Details |
| A07461 | 32486073 | Cancers (Basel) | Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice. | 2020 | Details |
| A07462 | 32485838 | Int J Mol Sci | The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07479 | 32478487 | Liver Int | Comparison of MAFLD and NAFLD diagnostic criteria in real world. | 2020 | Details |
| A07480 | 32478287 | Nat Metab | Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis. | 2020 | Details |
| A07481 | 32477116 | Front Pharmacol | Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. | 2020 | Details |
| A07484 | 32476802 | World J Gastroenterol | Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. | 2020 | Details |
| A07488 | 32476514 | Scand J Gastroenterol | Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A07493 | 32475638 | Biochem Biophys Res Commun | Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. | 2020 | Details |
| A07497 | 32472598 | FASEB J | Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr-/- .Leiden mice. | 2020 | Details |
| A07504 | 32469428 | Diabetes Metab Res Rev | Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease. | 2020 | Details |
| A07506 | 32467498 | Am J Ther | How to Reduce Cardiovascular Risk in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07507 | 32466319 | Int J Mol Sci | Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases. | 2020 | Details |
| A07510 | 32463484 | Hepatology | Protective and Detrimental Roles of p38α Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07512 | 32461992 | Biomed Res Int | Heme Oxygenase-1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis-Related Liver Fibrosis. | 2020 | Details |
| A07514 | 32461397 | Indian J Med Res | Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome. | 2020 | Details |
| A07518 | 32460476 | J Pathol Transl Med | A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy. | 2020 | Details |
| A07519 | 32460399 | Liver Int | Genetic variants in the MTHFR are not associated with fatty liver disease. | 2020 | Details |
| A07523 | 32457304 | Sci Rep | A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice. | 2020 | Details |
| A07526 | 32455155 | Regen Ther | Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles. | 2020 | Details |
| A07532 | 32454036 | Gastroenterology | ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. | 2020 | Details |
| A07535 | 32451920 | Obes Surg | Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients. | 2020 | Details |
| A07536 | 32451628 | J Gastroenterol | Confounding factors of non-invasive tests for nonalcoholic fatty liver disease. | 2020 | Details |
| A07537 | 32451205 | Ann Hepatol | Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population? | 2020 | Details |
| A07540 | 32450460 | Prostaglandins Leukot Essent Fatty Acids | Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease. | 2020 | Details |
| A07541 | 32450363 | Clin Gastroenterol Hepatol | Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07542 | 32450149 | Gastroenterology | Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122. | 2020 | Details |
| A07543 | 32448832 | Intern Med | SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology. | 2020 | Details |
| A07547 | 32447878 | Clin Mol Hepatol | Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years. | 2020 | Details |
| A07548 | 32446270 | Br J Pharmacol | Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway. | 2020 | Details |
| A07549 | 32446022 | Semin Arthritis Rheum | Safety of TNF inhibitors in rheumatic disease in case of NAFLD and cirrhosis. | 2020 | Details |
| A07565 | 32442221 | PLoS One | Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis. | 2020 | Details |
| A07573 | 32439605 | Drug Discov Today | Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment. | 2020 | Details |
| A07575 | 32438959 | Biomed Environ Sci | Peripheral Artery Disease and Risk of Fibrosis Deterioration in Nonalcoholic Fatty Liver Disease: A Prospective Investigation. | 2020 | Details |
| A07580 | 32436818 | Curr Pharm Des | The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07582 | 32436128 | High Blood Press Cardiovasc Prev | Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A07586 | 32434740 | Transplant Proc | The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post-Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. | 2020 | Details |
| A07588 | 32434697 | Transl Res | Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis. | 2020 | Details |
| A07589 | 32433419 | Eur J Gastroenterol Hepatol | Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system. | 2021 | Details |
| A07591 | 32432142 | World J Clin Cases | Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. | 2020 | Details |
| A07595 | 32431115 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. | 2020 | Details |
| A07598 | 32429653 | Pol J Pathol | Role of mast cells in the pathogenesis of liver fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A07599 | 32429590 | Nutrients | Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance. | 2020 | Details |
| A07603 | 32427918 | Sci Rep | Hepatic steatosis among people living with HIV in Southern Brazil: prevalence and risk factors. | 2020 | Details |
| A07609 | 32424494 | Adv Exp Med Biol | Non-alcoholic Fatty Liver Disease and Diabetes Mellitus. | 2021 | Details |
| A07614 | 32420347 | Biomed Res Int | The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods. | 2020 | Details |
| A07620 | 32417373 | Life Sci | CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease. | 2020 | Details |
| A07625 | 32416645 | Hepatology | Alanine Aminotransferase and Gamma-Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07627 | 32414883 | CMAJ Open | Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study. | 2020 | Details |
| A07629 | 32414752 | BMJ Open Gastroenterol | Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis. | 2020 | Details |
| A07633 | 32413995 | Genes (Basel) | Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07634 | 32413869 | Aging (Albany NY) | Overexpression of miR-142-5p inhibits the progression of nonalcoholic steatohepatitis by targeting TSLP and inhibiting JAK-STAT signaling pathway. | 2020 | Details |
| A07636 | 32413340 | Lancet Gastroenterol Hepatol | Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
| A07645 | 32410320 | Hepatol Res | Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A07648 | 32409850 | Internist (Berl) | [New pharmacological treatment options for nonalcoholic fatty liver disease]. | 2020 | Details |
| A07657 | 32407146 | Arch Physiol Biochem | trans-Chalcone inhibits transforming growth factor-β1 and connective tissue growth factor-dependent collagen expression in the heart of high-fat diet-fed rats. | 2020 | Details |